Literature DB >> 23456953

Search for varicella zoster virus and herpes simplex virus-1 in normal human cerebral arteries.

Maria A Nagel1, Alexander Choe, Nelly Khmeleva, Lindsey Overton, April Rempel, Ann Wyborny, Igor Traktinskiy, Don Gilden.   

Abstract

Virological confirmation of varicella zoster virus (VZV) vasculopathy is provided by presence of virus in the cerebral arteries, frequently associated with inflammation. Yet, cerebral arteries from normal subjects have never been studied for VZV DNA or antigen. We analyzed 63 human cerebral arteries from 45 subjects for VZV DNA and antigen, control herpes simplex virus (HSV)-1 DNA and antigen, and leukocyte-specific CD45 antigen. No cerebral arteries contained VZV or HSV-1 DNA or antigen; eight arteries from seven subjects contained leukocytes expressing CD45. Thus, the presence of VZV antigen in cerebral arteries of patients with stroke is likely to be clinically significant.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23456953      PMCID: PMC3644002          DOI: 10.1007/s13365-013-0155-0

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  9 in total

1.  Fatal varicella-zoster virus antigen-positive giant cell arteritis of the central nervous system.

Authors:  T M Berger; J H Caduff; J O Gebbers
Journal:  Pediatr Infect Dis J       Date:  2000-07       Impact factor: 2.129

2.  Varicella zoster virus vasculopathy: analysis of virus-infected arteries.

Authors:  M A Nagel; I Traktinskiy; Y Azarkh; B Kleinschmidt-DeMasters; T Hedley-Whyte; A Russman; E M VanEgmond; K Stenmark; M Frid; R Mahalingam; M Wellish; A Choe; R Cordery-Cotter; R J Cohrs; D Gilden
Journal:  Neurology       Date:  2011-07-13       Impact factor: 9.910

3.  Prevalence and abundance of latently transcribed varicella-zoster virus genes in human ganglia.

Authors:  Randall J Cohrs; Donald H Gilden
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

4.  Varicella zoster virus, a cause of waxing and waning vasculitis: the New England Journal of Medicine case 5-1995 revisited.

Authors:  D H Gilden; B K Kleinschmidt-DeMasters; M Wellish; E T Hedley-Whyte; B Rentier; R Mahalingam
Journal:  Neurology       Date:  1996-12       Impact factor: 9.910

5.  Herpes zoster ophthalmicus with contralateral hemiplegia: identification of cause.

Authors:  P W Doyle; G Gibson; C L Dolman
Journal:  Ann Neurol       Date:  1983-07       Impact factor: 10.422

6.  Subarachnoid hemorrhage and granulomatous angiitis of the basilar artery: demonstration of the varicella-zoster-virus in the basilar artery lesions.

Authors:  S Fukumoto; M Kinjo; K Hokamura; K Tanaka
Journal:  Stroke       Date:  1986 Sep-Oct       Impact factor: 7.914

7.  Thrombotic cerebral vasculopathy associated with herpes zoster.

Authors:  D Eidelberg; A Sotrel; D S Horoupian; P E Neumann; T Pumarola-Sune; R W Price
Journal:  Ann Neurol       Date:  1986-01       Impact factor: 10.422

8.  Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency.

Authors:  S Debrus; C Sadzot-Delvaux; A F Nikkels; J Piette; B Rentier
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

9.  Varicella-zoster virus vasculopathy: immune characteristics of virus-infected arteries.

Authors:  Maria A Nagel; Igor Traktinskiy; Kurt R Stenmark; Maria G Frid; Alexander Choe; Don Gilden
Journal:  Neurology       Date:  2012-12-12       Impact factor: 9.910

  9 in total
  7 in total

Review 1.  Infection and Stroke: an Update on Recent Progress.

Authors:  Eliza C Miller; Mitchell S V Elkind
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

2.  Association of varicella zoster virus with giant cell arteritis.

Authors:  Don Gilden
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2014-06-03

Review 3.  Varicella zoster virus vasculopathy: The expanding clinical spectrum and pathogenesis.

Authors:  Maria A Nagel; Dallas Jones; Ann Wyborny
Journal:  J Neuroimmunol       Date:  2017-03-18       Impact factor: 3.478

4.  Varicella zoster virus (VZV) in cerebral arteries of subjects at high risk for VZV reactivation.

Authors:  Maria A Nagel; Nelly Khmeleva; Alexander Choe; Jose Gutierrez; Don Gilden
Journal:  J Neurol Sci       Date:  2014-02-08       Impact factor: 3.181

Review 5.  Varicella zoster virus vasculopathy: clinical features and pathogenesis.

Authors:  Maria A Nagel
Journal:  J Neurovirol       Date:  2013-08-06       Impact factor: 2.643

6.  Detection of varicella zoster virus antigen and DNA in two cases of cerebral amyloid angiopathy.

Authors:  Teresa Mescher; Philip J Boyer; Andrew N Bubak; James E Hassell; Maria A Nagel
Journal:  J Neurol Sci       Date:  2021-01-09       Impact factor: 3.181

7.  Complications of varicella zoster virus reactivation.

Authors:  Maria A Nagel; Don Gilden
Journal:  Curr Treat Options Neurol       Date:  2013-08       Impact factor: 3.972

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.